M&A Deal Summary

Axion BioSystems Acquires CytoSMART

On March 21, 2022, Axion BioSystems acquired life science company CytoSMART

Acquisition Highlights
  • This is Axion BioSystems’ 1st transaction in the Life Science sector.
  • This is Axion BioSystems’ 1st transaction in the Netherlands.

M&A Deal Summary

Date 2022-03-21
Target CytoSMART
Sector Life Science
Buyer(s) Axion BioSystems
Deal Type Add-on Acquisition

Target

CytoSMART

Eindhoven, Netherlands
CytoSMART is a specialist in the development and manufacturing of live-cell imaging systems for life science laboratories. The company was founded by a team of biologists and engineers who were convinced that a new generation of miniaturized microscopes, powered by artificial intelligence for image analysis, would allow biologists to make discoveries more efficiently and at scale. Its microscopy solutions are used in research laboratories worldwide. CytoSMART was formed in 2012 and is headquartered in Eindhoven, the Netherlands.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Axion BioSystems

Atlanta, Georgia, United States

Category Company
Founded 2008
Sector Medical Products
DESCRIPTION

Axion BioSystems is a life science tools company focused on developing and commercializing label-free, bioelectronic assays used to study the function of live cells in vitro, to enable drug discovery, and disease modeling. Axion BioSystems was founded in 2008 and is based in Atlanta, Georgia.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Netherlands M&A 1 of 1
Year: 2022 M&A 1 of 1